Identification of a Clinical Score to Support the Clinician in Phase 2 of Covid-19

University of L'Aquila1 site in 1 country200 target enrollmentApril 1, 2020

ConditionsCovid19 Prognostic Parameters

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Covid19 Prognostic Parameters
Sponsor: University of L'Aquila
Enrollment: 200
Locations: 1
Primary Endpoint: Data collection of clinical and demographical parameters of patients affected by COVID-19
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of the study is to define the clinical and biochemical parameters that characterize COVID-19 patients with a negative prognostic evolution. Our clinical score will be capable to recognize patient with favorable prognosis or patient with poor prognosis by statistical data analysis.

Registry

clinicaltrials.gov

Start Date

April 1, 2020

End Date

December 1, 2020

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of L'Aquila

Responsible Party

Principal Investigator

Clara Balsano

Full Professor

University of L'Aquila

Eligibility Criteria

Inclusion Criteria

•patients over 18 and symptomatic and positive for COVID-19 by polymerase chain reaction assay for rhino-pharingeal swab

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Data collection of clinical and demographical parameters of patients affected by COVID-19

Time Frame: 8 months

Data about sex, age, symptom start date, vital parameters, comorbidity, symptoms, hematochemicals blood tests, therapy, oxygen support, radiology, condition evaluation will be manual collected.